REVENUE (Tables)

9 Months Ended

Sep. 30, 2019

REVENUE

Schedule of disaggregation of net sales by therapeutic categories for the Specialty segment and by product and service distribution channels for the PBM segment

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2019		2018		2019		2018
Specialty Segment:
Oncology	$	718,859	$	701,206	$	2,123,574	$	2,094,394
Specialty infusion		209,767		178,890		580,254		525,857
Immunology		135,740		135,397		412,268		413,948
Other		179,082		196,805		511,486		564,824
Total Specialty segment		1,243,448		1,212,298		3,627,582		3,599,023
PBM Segment:
Retail networks		48,604		126,082		173,800		417,370
Specialty pharmacy		23,156		22,470		57,323		67,784
Mail order		7,976		16,019		30,758		50,029
Other		2,764		5,362		8,849		14,965
Total PBM segment		82,500		169,933		270,730		550,148
Inter-segment eliminations		(24,751)		(8,897)		(52,683)		(17,275)
Total net sales	$	1,301,197	$	1,373,334	$	3,845,629	$	4,131,896